Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoglycans in muscular dystrophy.

A A Hack1, M E Groh, E M McNally

  • 1Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637, USA.

Microscopy Research and Technique
|February 19, 2000
PubMed
Summary

Abnormalities in sarcoglycans are common in muscular dystrophies, impacting skeletal and cardiac muscle. Research reveals sarcoglycans act as independent mediators of disease, affecting membrane permeability and apoptosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The sarcoglycan complex in striated and vascular smooth muscle.

Cold Spring Harbor symposia on quantitative biology·2003
Same author

Dysferlin protein analysis in limb-girdle muscular dystrophies.

Journal of molecular neuroscience : MN·2001
Same author

Cardiomyopathy in animal models of muscular dystrophy.

Current opinion in cardiology·2001
Same author

Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly.

The Journal of biological chemistry·2001
Same author

Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice.

Neuromuscular disorders : NMD·2001
Same author

Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.

Human gene therapy·2001

Area of Science:

  • Biochemistry
  • Molecular Cell Biology
  • Genetics

Background:

  • Muscular dystrophy is a genetic disorder affecting skeletal and cardiac muscles.
  • Mutations in dystrophin and sarcoglycans are key genetic defects.
  • Dystrophin defects disrupt sarcoglycan expression and localization, making sarcoglycan abnormalities common in dystrophies.

Purpose of the Study:

  • To explore the emerging understanding of the sarcoglycan complex.
  • To investigate sarcoglycan's role as an independent mediator of dystrophic pathology.
  • To elucidate the functional relationship between sarcoglycans and the dystrophin-glycoprotein complex.

Main Methods:

  • Biochemistry
  • Molecular cell biology
  • Human and mouse genetics

Related Experiment Videos

Main Results:

  • Sarcoglycan abnormalities are a common feature in various muscular dystrophies.
  • Absence of sarcoglycan leads to altered membrane permeability and apoptosis.
  • Beta- and delta-sarcoglycans may form the core of the sarcoglycan subcomplex.

Conclusions:

  • Sarcoglycan is an important, independent mediator of skeletal and cardiac muscle dystrophic pathology.
  • Sarcoglycan may couple mechanical and chemical signals in striated muscle.
  • Sarcoglycan might function as an independent signaling module, potentially independent of the dystrophin-dystroglycan-laminin axis.